Fatin Saparuddin1*, Mohd Naeem Mohd Nawi2, Liyana Ahmad Zamri1, Fazliana Mansor1, Mohd Fairulnizal Md Noh3
1. Endocrine and Metabolic Unit, Centre for Nutrition, Metabolism and Cardiovascular Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam 41070, Selangor, Malaysia
2. Nutrition Unit, Centre for Nutrition, Metabolism and Cardiovascular Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam 41070, Selangor, Malaysia
3. Centre for Nutrition, Metabolism and Cardiovascular Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam 41070, Selangor, Malaysia
*Corresponding author: Fatin Saparuddin.
ABSTRACT
INTRODUCTION: Women with obesity are at increased risk of chronic metabolic diseases; however, not all individuals present with the same metabolite profile. The two major phenotypes—metabolically healthy obese (MHO) and metabolically unhealthy obese (MUO)—exhibit distinct metabolic characteristics that may influence their predisposition to diseases. Exploring differences in metabolite profiles and metabolic interactions between these groups can provide valuable insights into the underlying biological processes associated with obesity.
OBJECTIVE(S): This study aimed to profile the metabolomics signatures of MHO and MUO women.
MATERIALS & METHODS: A total of 36 MHO serum samples and 34 MUO archived serum samples were randomly selected for the present study. All samples were obtained from overweight and obese women aged ≥18 years with a body mass index (BMI) ≥25 kg/m2. Untargeted metabolomics analysis was performed using proton nuclear magnetic resonance spectroscopy (1H NMR). Orthogonal partial least square discriminant analysis (OPLS-DA) and Pearson correlation analysis was conducted using Metaboanalyst 6.0.
RESULTS: The OPLS-DA model demonstrated moderate classification ability between the groups, with R2= 0.623 and Q2 = 0.302 (p < 0.01; validated via 100-permutation testing). Proline, glucose, caprate, τ-methylhistidine, and N-acetylglycine were identified as the top five metabolites contributing significantly to the discrimination between the MHO and MUO groups. Glucose, τ-methylhistidine, and N-acetylglycine were elevated in the MUO group, while proline and caprate were more abundant in the MHO group. Correlation analysis revealed distinct metabolic clustering patterns in each group. A single cluster exhibited strong positive correlations among proline, caprate, butyrate in the MHO group, potentially reflecting shared metabolic pathways. In contrast, the MUO group displayed three distinct clusters: Cluster 1 consisted of valine, isobutyrate, isoleucine, leucine, acetate, lysine, alanine, glycine, pyruvate, and tyrosine; Cluster 2 included ethylmalonate, caprate, isovalerate, valproate, lactate, butyrate, and proline; while Cluster 3 comprised betaine, glucose, choline, fructose, carnitine, N-acetylglycine, and trimethylamine-N-oxide (TMAO).
CONCLUSION: In conclusion, this study identified distinct metabolite profiles and correlation patterns between MHO and MUO women. These differences, reflected in metabolite levels and correlation structures, highlight distinct metabolic processes involving amino acid and energy metabolism that may underlie the contrasting health profiles of these obesity subtypes.
KEYWORDS: Metabolomics, MHO, MUO, Obesity, NMR


